BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 173657)

  • 1. Induction of herpes simplex virus immunity in newborn mice.
    Koyama H; Kasahara S
    Infect Immun; 1975 Dec; 12(6):1472-4. PubMed ID: 173657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
    Starr SE; Visintine AM; Tomeh MO; Nahmias AJ
    Proc Soc Exp Biol Med; 1976 May; 152(1):57-60. PubMed ID: 177992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced host defense mechanisms with levamisole in suckling rats.
    Fischer GW; Podgore JK; Bass JW; Kelley JL; Kobayaski GY
    J Infect Dis; 1975 Nov; 132(5):578-81. PubMed ID: 171323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delayed hypersensitivity to the antigens of the herpes simplex virus and herpetic resistance induced in mice by the administration of xenogeneic lymphocytic ultrafiltrates].
    Mats AN; Pozdniakov VI; Volkova MA; Perelygina OV; Perepechkina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):93-6. PubMed ID: 2554626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.
    Kitces EN; Morahan PS; Tew JG; Murray BK
    Infect Immun; 1977 Jun; 16(3):955-60. PubMed ID: 197013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus.
    Pack CD; Kumaraguru U; Suvas S; Rouse BT
    Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice.
    Shellam GR; Flexman JP
    J Virol; 1986 Apr; 58(1):152-6. PubMed ID: 3005643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice.
    Baron S; Worthington MG; Williams J; Gaines JW
    Nature; 1976 Jun; 261(5560):505-6. PubMed ID: 180414
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal transfer of low amounts of herpes simplex virus (HSV)-specific antibody protects newborn mice against HSV infection during acute maternal stress.
    Yorty JL; Bonneau RH
    Brain Behav Immun; 2004 Jan; 18(1):15-23. PubMed ID: 14651943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex vaccines.
    Whitley RJ; Meignier B
    Biotechnology; 1992; 20():223-54. PubMed ID: 1318135
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
    J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.
    McKendall RR
    Infect Immun; 1977 May; 16(2):717-9. PubMed ID: 193798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of herpes simplex virus diseases in man.
    Epstein JS; Quinnan GV
    Clin Dermatol; 1984; 2(2):133-46. PubMed ID: 6100714
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression and stability of herpes simplex virus antigens in Salmonella typhimurium.
    Bowen JC; Reddy RM; Alpar HO; Brown MR; Rouse BT
    Adv Exp Med Biol; 1995; 371B():1543-6. PubMed ID: 7502853
    [No Abstract]   [Full Text] [Related]  

  • 16. Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in mice.
    Lopez C; Ryshke R; Bennett M
    Infect Immun; 1980 Jun; 28(3):1028-32. PubMed ID: 6249746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunization of mice with specific HSV-1 glycoproteins.
    Chan WL
    Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2.
    Sturn B; Schneweis KE
    Med Microbiol Immunol; 1978 Jul; 165(2):119-27. PubMed ID: 209295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to synthetic herpes simplex virus peptides: the feasibility of a synthetic vaccine.
    Heber-Katz E; Dietzschold B
    Curr Top Microbiol Immunol; 1986; 130():51-64. PubMed ID: 3022991
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes simplex virus type 2 infection of neonatal mice.
    Baker DA; Plotkin SA
    Infection; 1978; 6(4):158-61. PubMed ID: 211091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.